
GP2 is a product and a source of collaboration. The individuals and groups that contribute to GP2 drive its strategy, its operations, and ultimately its impact. Read more.

At GP2, we are committed to creating a global research community with the tools and infrastructure to address emerging research needs and questions. Read more.

GP2 develops and maintains tools that assemble clinical and genetic data to help accelerate research across the Parkinson’s Disease Research community. Read more.
October 24, 2024
Training and Networking Working Group
Advancing Parkinson's Disease Research in Africa: A Strategic Training Framework of the Global Parkinson's Genetics Program
MD, Neurologist
Nomena Rasaholiarison
Faculty of Medicine, University of Fianarantsoa | Madagascar
Consultant Physician
Richard Walker, MD
NHS Foundation Trust | UK
Staff Scientist
Sara Bandres-Ciga, PharmD,PhD
National Institutes of Health | USA
Our website uses cookies to improve experiences and optimize our website. For more information, visit our privacy policy page